Gene Symbol | CTGF |
Entrez ID | 1490 |
Uniprot ID | P29279 |
Description | connective tissue growth factor |
Chromosomal Location | chr6: 131,948,176-131,951,373 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001502 |
cartilage condensation |
The condensation of mesenchymal cells that have been committed to differentiate into chondrocytes. |
IEA |
BP |
GO:0001503 |
ossification |
The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance. |
IEA |
BP |
GO:0001525 |
angiogenesis |
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
IEA |
BP |
GO:0001558 |
regulation of cell growth |
Any process that modulates the frequency, rate, extent or direction of cell growth. |
IEA |
BP |
GO:0001894 |
tissue homeostasis |
A homeostatic process involved in the maintenance of an internal steady state within a defined tissue of an organism, including control of cellular proliferation and death and control of metabolic function. |
IEA |
BP |
GO:0006367 |
transcription initiation from RNA polymerase II promoter |
Any process involved in the assembly of the RNA polymerase II preinitiation complex (PIC) at an RNA polymerase II promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription. |
TAS |
BP |
GO:0007155 |
cell adhesion |
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules. |
IBA |
BP |
GO:0007160 |
cell-matrix adhesion |
The binding of a cell to the extracellular matrix via adhesion molecules. |
IEA |
BP |
GO:0007229 |
integrin-mediated signaling pathway |
A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
IEA |
BP |
GO:0007267 |
cell-cell signaling |
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
IBA |
BP |
GO:0007568 |
aging |
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
IEA |
BP |
GO:0008284 |
positive regulation of cell proliferation |
Any process that activates or increases the rate or extent of cell proliferation. |
IEA |
BP |
GO:0008543 |
fibroblast growth factor receptor signaling pathway |
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands. |
IEA |
BP |
GO:0008544 |
epidermis development |
The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species. |
TAS |
BP |
GO:0009611 |
response to wounding |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism. |
TAS |
BP |
GO:0009749 |
response to glucose |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus. |
IEA |
BP |
GO:0010628 |
positive regulation of gene expression |
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IEA |
BP |
GO:0010629 |
negative regulation of gene expression |
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IEA |
BP |
GO:0016477 |
cell migration |
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. |
IEA |
BP |
GO:0030154 |
cell differentiation |
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
IEA |
BP |
GO:0030324 |
lung development |
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax. |
IEA |
BP |
GO:0032330 |
regulation of chondrocyte differentiation |
Any process that modulates the frequency, rate or extent of chondrocyte differentiation. |
IEA |
BP |
GO:0032355 |
response to estradiol |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
IEA |
BP |
GO:0032967 |
positive regulation of collagen biosynthetic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. |
IEA |
BP |
GO:0034059 |
response to anoxia |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating a decline in oxygen levels to trace amounts, <0.1%. |
IEA |
BP |
GO:0035556 |
intracellular signal transduction |
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
IEA |
BP |
GO:0035988 |
chondrocyte proliferation |
The multiplication or reproduction of chondrocytes by cell division, resulting in the expansion of their population. A chondrocyte is a polymorphic cell that forms cartilage. |
IEA |
BP |
GO:0043200 |
response to amino acid |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups. |
IEA |
BP |
GO:0043280 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process. |
IEA |
BP |
GO:0043434 |
response to peptide hormone |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals. |
IEA |
BP |
GO:0045597 |
positive regulation of cell differentiation |
Any process that activates or increases the frequency, rate or extent of cell differentiation. |
IDA |
BP |
GO:0046330 |
positive regulation of JNK cascade |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade. |
IDA |
BP |
GO:0050867 |
positive regulation of cell activation |
Any process that activates or increases the frequency, rate or extent of activation. |
IEA |
BP |
GO:0051385 |
response to mineralocorticoid |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mineralocorticoid stimulus. Mineralocorticoids are hormonal C21 corticosteroids synthesized from cholesterol and characterized by their similarity to aldosterone. Mineralocorticoids act primarily on water and electrolyte balance. |
IEA |
BP |
GO:0051496 |
positive regulation of stress fiber assembly |
Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts. |
IDA |
BP |
GO:0060401 |
cytosolic calcium ion transport |
The directed movement of calcium ions (Ca2+) into, out of or within the cytosol. |
IEA |
BP |
GO:0060452 |
positive regulation of cardiac muscle contraction |
Any process that increases the frequency, rate or extent of cardiac muscle contraction. |
IEA |
BP |
GO:0060548 |
negative regulation of cell death |
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. |
IBA |
BP |
GO:0070278 |
extracellular matrix constituent secretion |
The controlled release of molecules that form the extracellular matrix, including carbohydrates and glycoproteins by a cell. |
IEA |
BP |
GO:0070318 |
positive regulation of G0 to G1 transition |
A cell cycle process that activates or increases the rate or extent of the transition from the G0 quiescent state to the G1 phase. |
IEA |
BP |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
IDA |
BP |
GO:0070542 |
response to fatty acid |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fatty acid stimulus. |
IEA |
BP |
GO:0071897 |
DNA biosynthetic process |
The cellular DNA metabolic process resulting in the formation of DNA, deoxyribonucleic acid, one of the two main types of nucleic acid, consisting of a long unbranched macromolecule formed from one or two strands of linked deoxyribonucleotides, the 3'-phosphate group of each constituent deoxyribonucleotide being joined in 3',5'-phosphodiester linkage to the 5'-hydroxyl group of the deoxyribose moiety of the next one. |
IEA |
BP |
GO:0072593 |
reactive oxygen species metabolic process |
The chemical reactions and pathways involving a reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes, regulation of signal transduction and gene expression, and the oxidative damage to biopolymers. |
IEA |
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
TAS |
CC |
GO:0005578 |
proteinaceous extracellular matrix |
A layer consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or overlying cells such as endothelial and epithelial cells. The proteins are secreted by cells in the vicinity. An example of this component is found in Mus musculus. |
IEA |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IEA |
CC |
GO:0005794 |
Golgi apparatus |
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions. |
IDA |
CC |
GO:0005801 |
cis-Golgi network |
The network of interconnected tubular and cisternal structures located at the convex side of the Golgi apparatus, which abuts the endoplasmic reticulum. |
IEA |
CC |
GO:0005829 |
cytosol |
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
IEA |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
CC |
GO:0005938 |
cell cortex |
The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins. |
IEA |
CC |
GO:0043231 |
intracellular membrane-bounded organelle |
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. |
IDA |
CC |
GO:0048471 |
perinuclear region of cytoplasm |
Cytoplasm situated near, or occurring around, the nucleus. |
IEA |
MF |
GO:0001968 |
fibronectin binding |
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids. |
IEA |
MF |
GO:0005178 |
integrin binding |
Interacting selectively and non-covalently with an integrin. |
IBA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0005520 |
insulin-like growth factor binding |
Interacting selectively and non-covalently with an insulin-like growth factor, any member of a group of polypeptides that are structurally homologous to insulin and share many of its biological activities, but are immunologically distinct from it. |
IEA |
MF |
GO:0008022 |
protein C-terminus binding |
Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxy function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue. |
IPI |
MF |
GO:0008083 |
growth factor activity |
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
IEA |
MF |
GO:0008201 |
heparin binding |
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues. |
IBA |
Domain ID | Description |
---|---|
IPR000867 |
Insulin-like growth factor-binding protein, IGFBP |
IPR000884 |
Thrombospondin type-1 (TSP1) repeat |
IPR001007 |
VWFC domain |
IPR006207 |
Cystine knot, C-terminal |
IPR006208 |
Glycoprotein hormone subunit beta, cystine knot |
IPR009030 |
Growth factor receptor cysteine-rich domain |
IPR012395 |
IGFBP-related, CNN |
IPR017891 |
Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04371 |
Apelin signaling pathway |
KEGG |
hsa04390 |
Hippo signaling pathway |
KEGG |
WP3624 |
Lung fibrosis |
WikiPathways |
WP3968 |
CTGF-mediated hyperthermia resistance |
WikiPathways |
WP3668 |
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease |
WikiPathways |
WP3888 |
VEGFA-VEGFR2 Signaling Pathway |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0001418 |
Adenocarcinoma |
C0003504 |
Aortic Valve Insufficiency |
C0003873 |
Rheumatoid Arthritis |
C0011616 |
Contact Dermatitis |
C0017668 |
Focal Glomerulosclerosis |
C0018801 |
Heart Failure |
C0020538 |
Hypertensive Disease |
C0021361 |
Female Infertility |
C0023485 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma |
C0023890 |
Liver Cirrhosis |
C0024115 |
Lung Diseases |
C0024121 |
Lung Neoplasms |
C0033054 |
Prenatal Exposure Delayed Effects |
C0034069 |
Pulmonary Fibrosis |
C0235833 |
Congenital Diaphragmatic Hernia |
C0524909 |
Hepatitis B, Chronic |
Tissue | Cell Type |
---|---|
appendix |
lymphoid tissue |
endometrium |
cells in endometrial stroma |
smooth muscle |
smooth muscle cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
LRP1 |
4035 |
Q07954 |
0.52 |
AP3D1 |
8943 |
O14617 |
0.52 |
ITGA5 |
3678 |
P08648 |
0.55 |
ACTB |
60 |
P60709 |
0.68 |
FGFR3 |
2261 |
P22607 |
0.14 |
FGFR2 |
2263 |
P21802 |
0.14 |
FGFR1OP |
11116 |
O95684 |
0.14 |
ERBB4 |
2066 |
Q15303 |
0.52 |
HSPG2 |
3339 |
P98160 |
0.52 |
TGFB1 |
7040 |
P01137 |
0.52 |
TGFB2 |
7042 |
P61812 |
0.52 |
TGFB3 |
7043 |
P10600 |
0.52 |
EGFR |
1956 |
P00533 |
0.63 |
ELAVL1 |
1994 |
Q15717 |
0.63 |
LIMS1 |
3987 |
P48059 |
0.63 |
NOV |
4856 |
P48745 |
0.65 |
FBLN1 |
2192 |
P23142 |
0.75 |
FN1 |
2335 |
P02751 |
0.78 |
VEGFA |
7422 |
P15692 |
0.79 |